Skip to main content
. 2024 May 13;30(7):2049–2057. doi: 10.1038/s41591-024-02996-7

Extended Data Fig. 1. Effect of semaglutide treatment or placebo on waist circumference from baseline to week 104 by subgroups.

Extended Data Fig. 1

Data from the in-trial period. N = 17,604. P values represent test of no interaction effect. P values are two-sided and not adjusted for multiplicity. The dots show estimated treatment differences and the error bars show 95% confidence intervals. Details of the statistical models are available in Methods. BMI, body mass index; CI, confidence interval; CV, cardiovascular; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; ETD, estimated treatment difference; HbA1c, glycated hemoglobin; MI, myocardial infarction; PAD, peripheral artery disease; sema, semaglutide.